World Journal of Hepatology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 4

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7458)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-2) series.

Item

Count

PDF

344

WORD

HTML

3254

Figures (1-6)

585

Tables (1-2)

665

Sum=4923

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

657

Download

1873

Sum=2530

Apr 27, 2022 (publication date) through May 8, 2026

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Gantzel RH, Kjær MB, Jepsen P, Aagaard NK, Watson H, Gluud LL, Grønbæk H. Effects and safety of natriuretic peptides as treatment of cirrhotic ascites: A systematic review and meta-analysis. World J Hepatol 2022; 14(4): 827-845 [PMID: 35646272 DOI: 10.4254/wjh.v14.i4.827]
URL:	https://www.wjgnet.com/1948-5182/full/v14/i4/827.htm

Number	Citing Articles
1	Rasmus H. Gantzel, Emilie E. Møller, Niels K. Aagaard, Hugh Watson, Peter Jepsen, Henning Grønbæk. Randomized clinical trial on safety of the natriuretic peptide ularitide as treatment of refractory cirrhotic ascites. Hepatology Communications 2024; 8(7) doi: 10.1097/HC9.0000000000000481